首页 | 本学科首页   官方微博 | 高级检索  
     


Early Increases in Multiple Biomarkers Predict Subsequent Cardiotoxicity in Patients With Breast Cancer Treated With Doxorubicin,Taxanes, and Trastuzumab
Authors:Bonnie Ky  Mary Putt  Heloisa Sawaya  Benjamin French  James L. Januzzi Jr.  Igal A. Sebag  Juan Carlos Plana  Victor Cohen  Jose Banchs  Joseph R. Carver  Susan E. Wiegers  Randolph P. Martin  Michael H. Picard  Robert E. Gerszten  Elkan F. Halpern  Jonathan Passeri  Irene Kuter  Marielle Scherrer-Crosbie
Affiliation: Cardiovascular Institute, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania; Center for Clinical Epidemiology and Biostatistics, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania; Cardiac Ultrasound Laboratory and Division of Cardiology, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts;§ Echocardiography Laboratory and Cardiology Division, Sir Mortimer B. Davis-Jewish General Hospital and McGill University, Montreal, Quebec, Canada; Division of Cardiovascular Medicine, Cleveland Clinic Foundation, Cleveland, Ohio; Department of Medicine, Segal Cancer Center, Sir Mortimer B. Davis-Jewish General Hospital and McGill University, Montreal, Quebec, Canada;# Department of Cardiovascular Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas;∗∗ Division of Cardiovascular Medicine, Temple University, Philadelphia, Pennsylvania;†† Piedmont Heart Institute, Atlanta, Georgia;‡‡ Institute for Technology Assessment, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts;§§ Gillette Center for Breast Cancer, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts
Abstract:
Keywords:cardio-oncology   chemotherapy cardiotoxicity   trastuzumab cardiotoxicity
本文献已被 ScienceDirect 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号